You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
沃森生物(300142.SZ)半日收跌4.27% Q3淨利潤同比下降87.92%
格隆匯 10-29 12:04
格隆匯10月29日丨沃森生物(300142.SZ)上午盤中一度跌近8%報53.31元,創今年5月以來新低;半日收跌4.27%報55.4元,市值882億元。公司昨晚公佈業績顯示,第三季度營收7.79億元,同比下降21.53%;淨利潤4517萬元,同比下降87.92%;前三季度淨利潤3.6億元,同比下降16.33%。研究員稱,公司前三季投入核酸疫苗的研發及建疫苗廠房的資金較多,暫時影響第三季度利潤。另外新冠疫苗接種導致常規疫苗受到影響。目前mRNA疫苗還在三期臨牀,因為國內病例較少,所以進度比較慢,原本預計十一後可以結束臨牀,但目前還沒有消息。值得關注的是,三季度鍾睒晱的養生堂有限公司已經從二級市場買入1670萬股,位列第9大股東。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account